Multiple Myeloma & AL Amyloidosis (2 September 2026)

This first haematology seminar for patients is dedicated to multiple myeloma and AL amyloidosis.

Specialists from the Haematology Department of the Jules Bordet Institute will explain the mechanisms underlying these diseases, discuss the treatments currently available, highlight the opportunities offered by clinical research, and explore the role of physical activity in patient care.

Programme

2:00 – 2:30 pm
Registration and welcome

2:30 – 2:45 pm
Introduction
Prof. Nathalie Meuleman

2:45 – 3:15 pm
What is Multiple Myeloma? Causes, Disease Mechanisms and Risk Factors
Dr Marie Vercruyssen

3:15 – 3:45 pm
Taking Part in Clinical Research: What Opportunities Are Available for Patients?
Dr Julie Castiaux

3:45 – 4:05 pm
Moving Towards a Better Quality of Life: Physical Activity and Multiple Myeloma
Dr Julie Dallemagne & Mr Benjamin Depoorter

4:05 – 4:20 pm
Coffee break

4:20 – 4:50 pm
AL Amyloidosis: Understanding a Rare Disease
Prof. Nathalie Meuleman

4:50 – 5:20 pm
AL Amyloidosis: Treatment Options Available Today
Dr Ornella Rizzo

5:20 – 5:35 pm
Questions & Answers